Nestlé’s infant formula hydrolysate not linked to reduced dermatitis, EFSA concludes

Related Articles

FormattedPicture

BUSINESS NEWS

30 Jul 2021 --- This week in nutrition news, Bioiberica received certification for its Corporate Social Responsibility (CSR) management system, which aligns with the UN sustainable... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

27 Jul 2021 --- Baby nutrition company ByHeart has secured US$90 million in series B funding, which will accelerate the road to market for its infant formula. D1 Capital led the... Read More

FormattedPicture

REGULATORY NEWS

23 Jul 2021 --- The European Food Safety Authority (EFSA) has published its draft opinion on the safety of dietary sugars, which confirms various links between the intake of... Read More

FormattedPicture

BUSINESS NEWS

21 Jul 2021 --- A “difficult” infant nutrition market in Asia and a Thai court case has put pressure on FrieslandCampina’s profits for the first half of... Read More

FormattedPicture

FOOD RESEARCH

13 Jul 2021 --- Nestlé Health Science (NHSc)’s blend of human milk oligosaccharides (HMOs) is safe and beneficial for infants and young children with moderate to... Read More

trans